GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Creative Medical Technology Holdings Inc (NAS:CELZ) » Definitions » Accounts Receivable

CELZ (Creative Medical Technology Holdings) Accounts Receivable : $0.00 Mil (As of Sep. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Creative Medical Technology Holdings Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Creative Medical Technology Holdings's accounts receivables for the quarter that ended in Sep. 2024 was $0.00 Mil.

Accounts receivable can be measured by Days Sales Outstanding.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Creative Medical Technology Holdings's Net-Net Working Capital per share for the quarter that ended in Sep. 2024 was $4.46.


Creative Medical Technology Holdings Accounts Receivable Historical Data

The historical data trend for Creative Medical Technology Holdings's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creative Medical Technology Holdings Accounts Receivable Chart

Creative Medical Technology Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 - - - -

Creative Medical Technology Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Creative Medical Technology Holdings Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Creative Medical Technology Holdings Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Creative Medical Technology Holdings's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Creative Medical Technology Holdings's accounts receivable are only considered to be worth 75% of book value:

Creative Medical Technology Holdings's Net-Net Working Capital Per Share for the quarter that ended in Sep. 2024 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(6.26+0.75 * 0+0.5 * 0.003-0.331
-0-0)/1.32988
=4.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Creative Medical Technology Holdings Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Creative Medical Technology Holdings's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Creative Medical Technology Holdings Business Description

Traded in Other Exchanges
N/A
Address
211 E Osborn Road, Phoenix, AZ, USA, 85012
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
Executives
Timothy Warbington director, 10 percent owner, officer: President & CEO 211 E. OSBORN ROAD, PHOENIX AZ 85012
Michael H. Finger director 1551 N. DIANE ST., MESA AZ 85203-3850
Susan H Snow director 26 SEDGE FERN DRIVE, HILTON HEAD SC 29926
Bruce Steven Urdang director 5171 E. HAWTHORNE DR., FLAGSTAFF AZ 86004-7377
Thomas Ichim director 211 E. OSBORN RD, PHOENIX AZ 85012
Creative Medical Health Inc. 10 percent owner 211 E. OSBORN RD, PHOENIX AZ 85012
Timothy Herbst 10 percent owner 2031 W. PEORIA AVE., SUITE 250, PHOENIX AZ 85029
Amit Nilkanth Patel director 1040 CHARTWELL CT., SALT LAKE CITY UT 84121
Donald Dickerson director, officer: CFO & Sr.VP 822 VERA STREET, SOLANA BEACH CA 92075
Steven L White director, officer: President,Secretary,Treasurer 386 NORTH 210 EAST, MAPLETON UT 84664

Creative Medical Technology Holdings Headlines

From GuruFocus